Evaluating Stroke and Hemorrhage Risks Associated with Non–Vitamin K Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation - Quiz - MDSpire

Evaluating Stroke and Hemorrhage Risks Associated with Non–Vitamin K Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation

  • By

  • Marie C. Bradley

  • Andrew L. Simon

  • Joy Kolonoski

  • David J. Graham

  • Rongmei Zhang

  • John G. Connolly

  • April 24, 2026

  • 0 min

Share

Original Source(s)

Evaluating Stroke and Hemorrhage Risks Associated with Non–Vitamin K Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation

  • by Marie C. Bradley, Andrew L. Simon, Joy Kolonoski, David J. Graham, Rongmei Zhang, John G. Connolly

  • April 24, 2026

Related Content

Linking atrial fibrillation to cerebral small vessel disease: a cross-sectional study with predictive analytics

What RVO May Reveal About Systemic Health

TriNetX data presented at Retina World Congress linked BRVO and CRVO with increased risks of stroke, myocardial infarction, and carotid disease.

Association between blood pressure levels and risk of stroke in patients with atrial fibrillation: results from a prospective registry in Xinjiang, China